Trials / Completed
CompletedNCT00911924
A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, unmasked, evaluation of the iStent in patients that have primary open-angle glaucoma (OAG). Stent implantation in one eye will be used for analysis, with medication added at 6 months, as required.
Detailed description
One hundred patients will be enrolled in the study at up to 21 sites; follow-up is through 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iStent | Glaukos iStent, medication |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2009-06-03
- Last updated
- 2015-05-20
Locations
13 sites across 6 countries: Armenia, Austria, France, Germany, Italy, Spain
Source: ClinicalTrials.gov record NCT00911924. Inclusion in this directory is not an endorsement.